Trial intelligence / Profile preview

Amiloride for Proteinuria in CKD

NCT03170336Phase 4Completed

Sponsor
Guangdong Provincial People's Hospital
Start
Mar 2018
Primary completion
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of amiloride in chronic kidney disease (CKD), sponsored by Guangdong Provincial People's Hospital. Started Mar 2018; status: completed.

02

Drugs

amiloride
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT03170336.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03170336.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call